Skip to content

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Integrating Tobacco Cessation Coaching Sessions Into Radiation Medicine Treatment: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03135782
Enrollment
2
Registered
2017-05-01
Start date
2017-08-01
Completion date
2020-09-23
Last updated
2021-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma, Caregiver, Head and Neck Carcinoma, Lung Carcinoma, Prostate Carcinoma, Tobacco Use

Brief summary

This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.

Detailed description

PRIMARY OBJECTIVES: I. To determine if training providers on tobacco cessation resources increases the frequency of counseling and referrals at initial and follow-up consultations for cancer patients who use tobacco and are scheduled to receive radiation at Oregon Health and Science University (OHSU). SECONDARY OBJECTIVES: I. Increase provider frequency of tobacco use quantification and type. II. Increase frequency of provider assessment of tobacco cessation readiness in current users. III. Increase frequency and types of tobacco cessation resources and medicines offered and utilized. IV. Increase frequency and type of follow-up planned if referred to cessation resource. OUTLINE: MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training. PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions. PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed.

Interventions

Undergo motivational interviewing training

OTHERMedical Chart Review

Undergo medical chart review

OTHERQuestionnaire Administration

Ancillary studies

Attend phone or in-person motivational interviewing coaching sessions

Sponsors

Oregon Health and Science University
CollaboratorOTHER
OHSU Knight Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* MEDICAL CHART REVIEW * Pre-intervention: 200 patient records between January 1, 2016 and December 31, 2016 are subject to review; the first 50 records with a diagnoses of each cancer type: head and neck, lung, prostate, or breast will be utilized for the review * Post-intervention: 200 patient records receiving care beginning six months post training are subject to review; the first 50 records with a diagnoses of head and neck, lung, prostate, or breast will be utilized * PROVIDER TRAINING * OHSU Radiation Medicine department has agreed to participate as pilot department for this project; all active Radiation Medicine providers are requested to participate in the training; providers have the option to not participate * TOBACCO CESSATION COACHING * Patients who are at least 18 years of age * Speak English * Report tobacco use within the past 7 days * Willing to consider quitting smoking * Patients must be willing to meet four times in person or on the phone to discuss tobacco use * Patients must be willing to be audio recorded during the sessions * Patients who meet this criteria will be referred to OHSU Health Promotion Sports Medicine researcher, Carol DeFrancesco, to complete assessment using stages of change tobacco use readiness ruler and question set * Patient smoking status will be documented in their electronic health record, per routine care

Exclusion criteria

* Vulnerable Populations * The following groups will be excluded from participation: * Children * Decisionally impaired adults * Prisoners * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Change in frequency of tobacco counselBaseline up to 24 monthsWill be compared between the cohort of pre and post intervention. Will be summarized using descriptive statistics and compared using chi-square test by tumor type.

Secondary

MeasureTime frameDescription
Change in frequency and type of follow-up planned if referred to cessation resource assessed by medical chart reviewBaseline up to 24 monthsWill be summarized using descriptive statistics and compared using chi-square test by tumor type.
Change in frequency and types of tobacco cessation resources and medicines offered and utilized assessed by medical chart reviewBaseline up to 24 monthsWill be tested using a chi-squared test. If any expected cell count in the contingency table is lower than 5, we will instead use Fisher's exact test.
Change in frequency of provider assessment of tobacco cessation readiness in current users assessed by medical chart reviewBaseline up to 24 monthsWill be summarized using descriptive statistics and compared using chi-square test by tumor type.
Change in provider frequency of tobacco use quantification and type assessed by medical chart reviewBaseline up to 24 monthsWill be summarized using descriptive statistics and compared using chi-square test by tumor type. Will be tested using Z tests of proportion.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026